Role of serology and routine laboratory tests in childhood inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 8, Issue 5, 2002, Pages 325-329

  Khan, Khalid ^a,b   Schwarzenberg, Sarah Jane ^a   Sharp, Harvey ^a   Greenwood, Deborah ^a   Weisdorf Schindele, Sally ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MMC 185 ^*  (United States)

Author keywords

Inflammatory bowel disease; Screening; Serology

Indexed keywords

BIOCHEMICAL MARKER; FUNGUS ANTIBODY; HEMOGLOBIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; BLOOD ANALYSIS; CHILD; CHILDHOOD DISEASE; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC VALUE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RECTUM HEMORRHAGE; SACCHAROMYCES CEREVISIAE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROLOGY; SYMPTOMATOLOGY; ULCERATIVE COLITIS;

EID: 0036743083     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200209000-00003     Document Type: Article

References (16)

1. Baldassano RN, Piccoli DA. Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am 1999; 28:445-58.
2. Nielsen OH, Vainer B, Soren M, et al. Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol 2000;95:359-67.
3. Sendid B, Colombel JF, Jaquinot PM, et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diag Lab Immunol 1996;3:219-26.
4. Vidrich A, Lee J, James E, et al. Segregation of pANCA recognition by DNase treatment: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitiS. J Clin Immunol 1995; 15:293-9.
5. Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998;42:788-91.
6. Hoffenberg EJ, Fidanza S, Sauaia A, et al. Serologic testing for inflammatory bowel disease. J Pediatr 1999; 134:447-52.
7. Ruemmele FM, Targan SR, Levy G, et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998;115:822-9.
8. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's disease activity index. Gastroenterology 1979;77:843-6.
9. Sutton CL, Yang H, Li Z, et al. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut 2000;46: 58-63.
10. Rutgeerts P, Vermeire S. Clinical value of the detection of antibodies in the serum for the diagnosis and treatment of inflammatory bowel disease. Gastroenterology 1998;115:1006-9.
11. Sander U, Kunze I, Broker M, et al. Humoral immune response to a 200-kDa glycoprotein antigen of Saccharomyces cerevisiae is common in man. Immumol Lett 1997;61:113-7.
12. Escher JC. Serological tests are helpful in managing but not in diagnosing inflammatory bowel disease [Comment]. Inflamm Bowel Dis 2002;8:230-31.
13. Abreu MT. Serological tests are helpful in managing inflammatory bowel disease. Inflamm Bowel Dis 2002;8:224-6.
14. Koutroubakis IE, Petinaki E, Mouzas IA, et al. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am J Gastroenterol 2001;96:449-54.
15. Present DH. Serological tests are not helpful in managing inflammatory bowel disease. Inflamm Bowel Dis 2002;8:227-9.
16. Dubinsky MC, Ofman JJ, Urman M, et al. Clinical utility of sero-diagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol 2001;96:758-65.